Tracked Foley catheter for motion compensation during fusion image-guided prostate procedures: a phantom study.
Focal therapy
Image-guided biopsy
Prostatic neoplasms
Spatial navigation
Surgery (computer-assisted)
Journal
European radiology experimental
ISSN: 2509-9280
Titre abrégé: Eur Radiol Exp
Pays: England
ID NLM: 101721752
Informations de publication
Date de publication:
16 04 2020
16 04 2020
Historique:
received:
27
08
2019
accepted:
17
02
2020
entrez:
18
4
2020
pubmed:
18
4
2020
medline:
29
4
2021
Statut:
epublish
Résumé
Uncorrected patient or prostate motion may impair targeting prostate areas during fusion image-guided procedures. We evaluated if a prototype "tracked Foley catheter" (TFC) could maintain fusion image alignment after simulated organ motion. A pelvic phantom model underwent magnetic resonance imaging (MRI), and the prostate was segmented. The TFC was placed in the phantom. MRI/ultrasound (US) fusion was performed. Four trials were performed varying motion and TFC presence/absence: (1) TFC/no-motion, (2) TFC/motion, (3) no-TFC/no-motion, and (4) no-TFC/motion. To quantify image alignment, screen captures generated Dice similarity coefficient (DSC) and offset distances (ODs) (maximal US-to-MRI distance between edges on fusion images). Three anatomical targets were identified for placement of a needle under fusion guidance. A computed tomography scan was used to measure system error (SE), i.e., the distance from needle tip to intended target. The TFC presence improved MRI/US alignment by DSC 0.88, 0.88, 0.74, and 0.61 in trials 1, 2, 3, and 4, respectively. Both OD (trial 2 versus trial 4, 4.85 ± 1.60 versus 25.29 ± 6.50 mm, p < 0.001) and SE (trial 2 versus trial 4, 6.35 ± 1.31 versus 32.16 ± 6.50 mm, p < 0.005) were significantly lower when the TFC was present after artificial motion, and significantly smaller OD when static (trial 1 versus trial 3, 4.29 ± 1.24 versus 6.42 ± 2.29 mm, p < 0.001). TFC provided better image alignment with or without simulated motion. This may overcome system limitations, allowing for more accurate fusion image alignment during fusion-guided biopsy, ablation, or robotic prostatectomy.
Sections du résumé
BACKGROUND
Uncorrected patient or prostate motion may impair targeting prostate areas during fusion image-guided procedures. We evaluated if a prototype "tracked Foley catheter" (TFC) could maintain fusion image alignment after simulated organ motion.
METHODS
A pelvic phantom model underwent magnetic resonance imaging (MRI), and the prostate was segmented. The TFC was placed in the phantom. MRI/ultrasound (US) fusion was performed. Four trials were performed varying motion and TFC presence/absence: (1) TFC/no-motion, (2) TFC/motion, (3) no-TFC/no-motion, and (4) no-TFC/motion. To quantify image alignment, screen captures generated Dice similarity coefficient (DSC) and offset distances (ODs) (maximal US-to-MRI distance between edges on fusion images). Three anatomical targets were identified for placement of a needle under fusion guidance. A computed tomography scan was used to measure system error (SE), i.e., the distance from needle tip to intended target.
RESULTS
The TFC presence improved MRI/US alignment by DSC 0.88, 0.88, 0.74, and 0.61 in trials 1, 2, 3, and 4, respectively. Both OD (trial 2 versus trial 4, 4.85 ± 1.60 versus 25.29 ± 6.50 mm, p < 0.001) and SE (trial 2 versus trial 4, 6.35 ± 1.31 versus 32.16 ± 6.50 mm, p < 0.005) were significantly lower when the TFC was present after artificial motion, and significantly smaller OD when static (trial 1 versus trial 3, 4.29 ± 1.24 versus 6.42 ± 2.29 mm, p < 0.001).
CONCLUSION
TFC provided better image alignment with or without simulated motion. This may overcome system limitations, allowing for more accurate fusion image alignment during fusion-guided biopsy, ablation, or robotic prostatectomy.
Identifiants
pubmed: 32300896
doi: 10.1186/s41747-020-00147-4
pii: 10.1186/s41747-020-00147-4
pmc: PMC7163002
doi:
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
24Subventions
Organisme : Intramural NIH HHS
ID : ZIA CL040015
Pays : United States
Références
J Vasc Interv Radiol. 2010 Aug;21(8 Suppl):S257-63
pubmed: 20656236
Expert Rev Anticancer Ther. 2017 Aug;17(8):737-743
pubmed: 28635336
CA Cancer J Clin. 2016 Jul;66(4):326-36
pubmed: 26594835
Minim Invasive Ther Allied Technol. 2007;16(4):196-204
pubmed: 17763092
Eur Urol. 2017 Mar;71(3):353-365
pubmed: 27543165
Biomed Res Int. 2014;2014:465816
pubmed: 25250323
J Vasc Interv Radiol. 2007 Jan;18(1 Pt 1):9-24
pubmed: 17296700
Med Biol Eng Comput. 2010 Feb;48(2):103-11
pubmed: 20041312
Clin Imaging. 2020 Jan;59(1):1-7
pubmed: 31715511
BJU Int. 2018 May;121(5):716-724
pubmed: 28796935
Future Oncol. 2017 Apr;13(8):727-741
pubmed: 27882770
Radiology. 2018 May;287(2):534-542
pubmed: 29361246
Comput Aided Surg. 2008 Sep;13(5):255-64
pubmed: 18821344
Int J Comput Assist Radiol Surg. 2013 Nov;8(6):937-44
pubmed: 23532560
Radiographics. 2011 May-Jun;31(3):677-703
pubmed: 21571651
IEEE Trans Med Imaging. 2014 Aug;33(8):1702-25
pubmed: 24816547
Biomed Res Int. 2014;2014:819360
pubmed: 25525605
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
Magn Reson Imaging Clin N Am. 2014 May;22(2):135-44, v
pubmed: 24792674
Gland Surg. 2018 Apr;7(2):89-102
pubmed: 29770305
Med Oncol. 2018 Sep 14;35(11):148
pubmed: 30218382
J Urol. 2011 Oct;186(4):1281-5
pubmed: 21849184
J Endourol. 2017 Apr;31(S1):S30-S37
pubmed: 28355119
Prostate Cancer Prostatic Dis. 2017 Dec;20(4):436-441
pubmed: 28762373
Radiology. 2013 Aug;268(2):461-9
pubmed: 23579051
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
J Urol. 2017 Oct;198(4):839-847
pubmed: 28396184
Eur Urol. 2015 Jul;68(1):8-19
pubmed: 25454618
Eur Urol Focus. 2018 Mar;4(2):219-227
pubmed: 28753777
Prog Biophys Mol Biol. 2005 Feb-Apr;87(2-3):241-6
pubmed: 15556662
Eur Urol. 2017 Jan;71(1):17-34
pubmed: 27595377